Dr. Martens plc

LSE DOCS.L

Dr. Martens plc EPS (Diluted) for the year ending March 31, 2024: USD 0.09

Dr. Martens plc EPS (Diluted) is USD 0.09 for the year ending March 31, 2024, a -44.74% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Dr. Martens plc EPS (Diluted) for the year ending March 31, 2023 was USD 0.16, a -32.20% change year over year.
Dr. Martens plc EPS (Diluted) for the year ending March 31, 2022 was USD 0.24, a 394.50% change year over year.
Dr. Martens plc EPS (Diluted) for the year ending March 31, 2021 was USD 0.05, a -81.65% change year over year.
Dr. Martens plc EPS (Diluted) for the year ending March 31, 2020 was USD 0.26, a 1,062.31% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

LSE: DOCS.L

Dr. Martens plc

CEO	Mr. Kenneth Wilson
IPO Date	Jan. 29, 2021
Location	United Kingdom
Headquarters	28 Jamestown Road
Employees	2,630
Sector	Consumer Discretionary
Industries Footwear

Description

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Key trends

Past 5 years